Hendy Pharmaceutical announced that the company's wholly-owned subsidiary, Wuhan Encyclopedia Pharmaceutical Development Co., Ltd. and Shanghai Yiyihong Technology Co., Ltd. jointly established the Shanghai Hongyidi Technology Partnership. Shanghai Hongyidi plans to invest in Ningbo Zhixing Yueheng Venture Capital Partnership with its own capital of no more than 100 million yuan, accounting for 3.2258% of the fund's target total pledged capital. The fund aims to invest a total of 3.1 billion yuan. The general partner is Shanghai Zhengxinggu Investment Management Co., Ltd., which mainly invests in artificial intelligence models, hardware, and application-related targets in biomedicine and other fields. This investment does not constitute a related transaction or major asset restructuring.

Hendy Pharmaceutical announced that the company's wholly-owned subsidiary, Wuhan Encyclopedia Pharmaceutical Development Co., Ltd. and Shanghai Yiyihong Technology Co., Ltd. jointly established the Shanghai Hongyidi Technology Partnership. Shanghai Hongyidi plans to invest in Ningbo Zhixing Yueheng Venture Capital Partnership with its own capital of no more than 100 million yuan, accounting for 3.2258% of the fund's target total pledged capital. The fund aims to invest a total of 3.1 billion yuan. The general partner is Shanghai Zhengxinggu Investment Management Co., Ltd., which mainly invests in artificial intelligence models, hardware, and application-related targets in biomedicine and other fields. This investment does not constitute a related transaction or major asset restructuring.